(Q46038295)

18 December 2017

title

Sunitinib-resistant gastrointestinal stromal tumors harbor cis-mutations in the activation loop of the KIT gene. (English)

1 reference

18 December 2017

4

Toshihiko Doi

1 reference

18 December 2017

Kuniaki Shirao

5

object named as

Kuniaki Shirao

1 reference

18 December 2017

author name string

Toshirou Nishida

1

1 reference

18 December 2017

Tsuyoshi Takahashi

2

1 reference

18 December 2017

Akiko Nishitani

3

1 reference

18 December 2017

Yoshito Komatsu

6

1 reference

18 December 2017

Kiyokazu Nakajima

7

1 reference

18 December 2017

Seiichi Hirota

8

1 reference

18 December 2017

Japanese Study Group on GIST

9

1 reference

18 December 2017

publication date

24 April 2009

1 reference

18 December 2017

International Journal of Clinical Oncology

published in

1 reference

18 December 2017

volume

14

1 reference

18 December 2017

issue

2

1 reference

18 December 2017

page(s)

143-149

1 reference

18 December 2017

https://scigraph.springernature.com/pub.10.1007/s10147-008-0822-y

exact match

0 references

cites work

Late resistance to imatinib therapy in a metastatic gastrointestinal stromal tumour is associated with a second KIT mutation

1 reference

12 December 2020

Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation

1 reference

12 December 2020

Structural basis for the autoinhibition of c-Abl tyrosine kinase

1 reference

12 December 2020

Molecular correlates of imatinib resistance in gastrointestinal stromal tumors.

1 reference

12 December 2020

Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants

1 reference

12 December 2020

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome

1 reference

12 December 2020

A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors

1 reference

12 December 2020

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

12 December 2020

PDGFRA activating mutations in gastrointestinal stromal tumors.

1 reference

12 December 2020

Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate

1 reference

12 December 2020

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

1 reference

12 December 2020

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib

1 reference

12 December 2020

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

1 reference

12 December 2020

Differential expression of connexin 43 in gastrointestinal stromal tumours of gastric and small intestinal origin.

1 reference

12 December 2020

Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors under treatment with imatinib mesylate

1 reference

12 December 2020

Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations

1 reference

12 December 2020

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

1 reference

12 December 2020

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

1 reference

12 December 2020

Effect of food on the pharmacokinetics of sunitinib malate (SU11248), a multi-targeted receptor tyrosine kinase inhibitor: results from a phase I study in healthy subjects

1 reference

12 December 2020

Gastrointestinal stromal tumour.

1 reference

12 December 2020

Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors.

1 reference

12 December 2020

Familial gastrointestinal stromal tumours with germline mutation of the KIT gene.

1 reference

12 December 2020

Secondary mutations in the kinase domain of the KIT gene are predominant in imatinib-resistant gastrointestinal stromal tumor

1 reference

12 December 2020

Sorafenib Inhibits the Imatinib-Resistant KITT670I Gatekeeper Mutation in Gastrointestinal Stromal Tumor

1 reference

12 December 2020

10.1007/S10147-008-0822-Y

Identifiers

DOI

1 reference

18 December 2017

PubMed ID

19390946

1 reference

18 December 2017